Tara Knezevic

Ms. Tara Knezevic


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
ARAndrea Radalj
Andrea Radalj
ANAleksandar Nikšić
Aleksandar Nikšić
JTJelena Trajkovic
Jelena Trajkovic
TKTara Knezevic
Tara Knezevic
MJMarko Jankovic
Marko Jankovic
PKPredrag Kolarz
Predrag Kolarz
Airborne pathogens, though a minor fraction of airborne particles, can cause infections, intoxications, or allergic reactions through respiration, dermal contact, or ingestion. The SARS-CoV-2 pandemic has underscored the significance of mitigating airborne microbial threats. Traditional air ionization methods, such as dielectric barrier discharge and metal tip corona discharge, produce ozone, a reactive and potentially harmful byproduct. However, carbon-fiber ionizers (CFIs) generate high concentrations of ions with minimal ozone production, making them a safer alternative. Operating at voltages below 5 kV, CFIs are more efficient than their metallic counterparts. This review focuses on the antimicrobial efficacy of CFIs, which produce unipolar ions that can disrupt microbial membranes, leading to cell death. Compared to ultraviolet light sterilization, CFIs are cost-effective and suitable for small spaces. The literature review highlights the need for comprehensive studies to evaluate the real-world application and effectiveness of CFIs. Many existing studies are limited by small-scale testing and insufficient data reporting, complicating comparative analyses. Our work aims to provide a detailed perspective on CFIs, examining their impact on various microorganisms, ion efficacy, ionization outcomes, and ozone generation levels. By addressing these aspects, the review seeks to offer an updated understanding of CFIs’ antimicrobial capabilities and to identify limitations in current research, paving the way for more informed and effective air purification strategies.

Verified
Journal Article
Open access
PDF file
MJMarko Jankovic
Marko Jankovic
TKTara Knezevic
Tara Knezevic
ATAna Tomic
Ana Tomic
OMOgnjen Milicevic
Ognjen Milicevic
TJTanja P Jovanovic
Tanja P Jovanovic
MBMilena Todorovic Balint
Milena Todorovic Balint
The oncogenicity of the human cytomegalovirus (CMV) is currently being widely debated. Most recently, mounting clinical evidence suggests an anti-cancer effect via CMV-induced T cell-mediated tumor destruction. However, the data were mostly obtained from single-center studies and in vitro experiments. Broad geographic coverage is required to offer a global perspective. Our study examined the correlation between country-specific CMV seroprevalence (across 73 countries) and the age-standardized incidence rate (of 34 invasive tumors). The populations studied were stratified according to decadal age periods as the immunologic effects of CMV seropositivity may depend upon age at initial infection. The International Agency for Research on Cancer of the World Health Organization (IARC WHO) database was used. The multivariate linear regression analysis revealed a worldwide inverse correlation between CMV seroprevalence and the incidences of 62.8% tumors. Notably, this inverse link persists for all cancers combined (Spearman’s ρ = −0.732, p < 0.001; β = −0.482, p < 0.001, adjusted R2 = 0.737). An antithetical and significant correlation was also observed in particular age groups for the vast majority of tumors. Our results corroborate the conclusions of previous studies and indicate that this oncopreventive phenomenon holds true on a global scale. It applies to a wide spectrum of cancer histologies, additionally supporting the idea of a common underlying mechanism—CMV-stimulated T cell tumor targeting. Although these results further advance the notion of CMV-based therapies, in-depth investigation of host–virus interactions is still warranted.

30 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MJMarko Jankovic
Marko Jankovic
TKTara Knezevic
Tara Knezevic
TJTanja Jovanovic
Tanja Jovanovic
MBMilena Todorovic Balint
Milena Todorovic Balint
IDIrena Djunic
Irena Djunic
Aleksandra KneževićAleksandra Knežević
Aleksandra Knežević
The oncogenicity of the human cytomegalovirus (CMV) is debated to this day. In recent years, mounting evidence addresses an anti-cancer effect via T cell-mediated CMV-targeted tumor de-struction. However, the data mostly comes from single-center studies and in vitro experiments. Broad geographic coverage is required to offer a global perspective. This study examined the correlation between country-specific CMV seroprevalence (n=73) and age-standardized inci-dence rates for 34 tumors using data obtained from the International Agency for Research on Cancer of the World Health Organization. The association between CMV and cancer incidences in 10-year age increments was also analyzed. The study revealed a worldwide inverse correlation between CMV seroprevalence and incidences of 88.2% tumors. Notably, this inverse link persists for all cancers combined (Spearman’s ρ= -0.732, p= 0.001). An antithetical and significant correlation is also observed in particular age groups for the vast majority of tumors. Our results corroborate the conclusions of previous studies and indicate that this phenomenon holds true on a global scale. It applies to a wide spectrum of cancer histologies, suggesting a common under-lying mechanism – CMV-stimulated T cell tumor targeting. Although these results further advance the notion of CMV-based therapies, further in-depth investigation of host-virus interactions is warranted.